Lisi, L <br/><br/>
Rapamycin reduces clinical signs and neuropathic pain in a chronic model of experimental autoimmune encephalomyelitis.  [electronic resource] 

 -  Journal of neuroimmunology  Feb 2012 
 - 43-51 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1872-8421 
<br/><br/><label>Standard No.: </label>10.1016/j.jneuroim.2011.12.018  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Analysis of Variance<br/>Animals<br/>Cytokines--metabolism<br/>Disease Models, Animal<br/>Encephalomyelitis, Autoimmune, Experimental--chemically induced<br/>Female<br/>Gene Expression Regulation--drug effects<br/>Glial Fibrillary Acidic Protein--metabolism<br/>Glycoproteins--toxicity<br/>Hyperalgesia--drug therapy<br/>Immunosuppressive Agents--therapeutic use<br/>Mice<br/>Mice, Inbred C57BL<br/>Myelin Basic Protein--genetics<br/>Myelin Sheath--metabolism<br/>Myelin-Oligodendrocyte Glycoprotein<br/>Neuralgia--drug therapy<br/>Pain Threshold--drug effects<br/>Peptide Fragments--toxicity<br/>Pertussis Toxin--toxicity<br/>RNA, Messenger--metabolism<br/>Sirolimus--therapeutic use<br/>T-Lymphocytes--drug effects<br/>Time Factors